Jerald Korn - 21 Mar 2022 Form 3 Insider Report for Epizyme, Inc.

Role: Chief Operating Officer
Signature: /s/ John Weidenbruch, attorney in fact
Issuer symbol: N/A
Transactions as of: 21 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 21 Mar 2022, 18:04:26 UTC
Previous filing: 02 Mar 2022
Next filing: 04 Apr 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney